Santiago Ponce-Aix
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Modelling and Implementation of a Precision-Oncology Data-Integration Platform for Real-Word Molecular Tumor Borad Decision-Making.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Modelling and Implementation of a Precision-Oncology Data-Integration Platform for Real-Word Molecular Tumor Borad Decision-Making.
Journal: Studies in health technology and informatics
Published: May 23, 2026
The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial.
Journal: The oncologist
Published: March 20, 2026
Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.
Journal: Biomarker research
Published: January 09, 2026
Emerging Targeted Therapies for HER2-Mutant NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 02, 2025
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2025
Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scans.
Journal: Frontiers in oncology
Published: August 17, 2025
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.
Journal: Drugs & aging
Published: April 28, 2025
Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics.
Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics.
Journal: Studies in health technology and informatics
Published: April 09, 2025
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 11, 2024
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 18, 2024
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
Journal: Cancer treatment reviews
Published: February 10, 2024
Last Updated: 09/26/2026